Delving into the Latest Updates on Baiaoxin Management (Shanghai) Co., Ltd. with Synapse

Overview

Primary Objective: To evaluate the long-term safety and tolerability of rimegepant ODT 75 mg taken as needed (PRN). Secondary Objective: To evaluate the number of headache days and severity of migraine attacks during long-term treatment with rimegepant ODT 75 mg (PRN) compared to the observation period.

Start Date19 May 2022

Sponsor / Collaborator

Biohaven Pharmaceutical Ireland DAC

[+3]

CTR20213162

/ CompletedPhase 1

一项在中国健康受试者中评Troriluzole（BHV-4157）280mg单次和多次给药后的安全性、耐受性和药代动力学特征的I期、随机、双盲、安慰剂对照研究

[Translation] A Phase I, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetic characteristics of Troriluzole (BHV-4157) 280 mg after single and multiple doses in healthy Chinese subjects

主要目的：评估在中国健康受试者中单次（280 mg）和多次（280 mg/日，连续5天）给药Troriluzole后的安全性和耐受性。次要目的：评估在中国健康受试者中单次（280 mg）和多次（280 mg/日，连续5天）给药Troriluzole后利鲁唑的药代动力学（PK）特征。

[Translation]

Primary objective: To evaluate the safety and tolerability of troriluzole after single (280 mg) and multiple (280 mg/day, 5 consecutive days) administration in healthy Chinese subjects. Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of riluzole after single (280 mg) and multiple (280 mg/day, 5 consecutive days) administration of troriluzole in healthy Chinese subjects.

Start Date03 Mar 2022

Sponsor / Collaborator

Baiaoxin Management (Shanghai) Co., Ltd.

[+1]

100 Clinical Results associated with Baiaoxin Management (Shanghai) Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Baiaoxin Management (Shanghai) Co., Ltd.

Login to view more data

100 Deals associated with Baiaoxin Management (Shanghai) Co., Ltd.

Login to view more data

100 Translational Medicine associated with Baiaoxin Management (Shanghai) Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Nov 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

3

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Trigriluzole ( EAAT2 x Nav1.5 )	Spinocerebellar Ataxias More	Discontinued
Verdiperstat ( MPO )	Multiple System Atrophy More	Discontinued
Rimegepant Sulfate ( CGRP receptor )	Migraine Disorders More	Discontinued